Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug entities : Moderna, inc. save search
Ministry of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.222
Published: 2022-11-01 (Crawled : 09:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
covid-19 drug japan change authorization
Ministry Of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.214
Published: 2022-09-12 (Crawled : 12:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: -0.2%
H: 1.96%
C: -1.18%
covid-19 drug japan authorization
Global Lumakras Drug Market By Therapy Type, Disease Indication, and Region (Including COVID-19 Impact Analysis): A Report by Absolute Markets Insights
Published: 2022-03-14 (Crawled : 16:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.01%
H: 0.71%
C: 0.0%
RVMD | $35.56 -1.93% -1.97% 1.2M
|
Health Technology
|
| O: 0.15%
H: 0.72%
C: -9.31%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 1.45%
H: 18.94%
C: 7.04%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.78%
H: 3.11%
C: -5.4%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 1.34%
H: 0.0%
C: 0.0%
covid-19 lumakras drug covid disease report therapy
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea
Published: 2021-12-14 (Crawled : 07:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
CTLT | $55.95 -0.14% 0.0% 2M
|
Health Technology
|
| O: 0.26%
H: 0.44%
C: -0.68%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
covid-19 drug covid food authorization vaccine
Generate Biomedicines Announces First External Equity Raise of $370 Million to Advance Its Drug Generation Platform
Published: 2021-11-18 (Crawled : 11:00) - biospace.com/
OMGA | $2.335 -0.21% -0.21% 200K
|
|
| O: 5.9%
H: 3.73%
C: 1.24%
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: 2.97%
H: 1.28%
C: -4.12%
SGTX | $22.47 -2.56% 0.0% 0
|
Health Technology
|
| O: -1.13%
H: 4.17%
C: 2.29%
MCRB | $0.7295 -4.01% -4.18% 5.8M
|
Health Technology
|
| O: 1.57%
H: 3.58%
C: 3.34%
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 0.07%
H: 0.37%
C: -0.95%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 4.83%
H: 2.87%
C: 2.15%
FHTX | $5.21 0.97% 0.96% 110K
|
Health Technology
|
| O: 0.68%
H: 6.55%
C: 2.48%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: -2.27%
H: 1.36%
C: -7.18%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: -0.71%
H: 0.61%
C: -5.11%
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: 2.93%
H: 1.32%
C: -3.69%
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: -0.66%
H: 0.27%
C: -1.33%
drug platform
Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine
Published: 2021-08-25 (Crawled : 17:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: -0.82%
H: 5.64%
C: 1.58%
covid food vaccine drug license submission application
Moderna Announces New Drug Substance Production Agreement with Lonza in the Netherlands
Published: 2021-06-02 (Crawled : 11:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.15%
C: -0.78%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: -0.41%
H: 5.76%
C: 4.19%
new drug drug
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna’s COVID-19 Vaccine
Published: 2021-05-21 (Crawled : 00:20) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 1.78%
H: 0.21%
C: -4.43%
covid food vaccine drug authorized
Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S.
Published: 2020-12-30 (Crawled : 18:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 3.51%
H: 0.46%
C: -6.14%
drug
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.